{"id":"W2058098342","doi":"10.1097/00001813-200210000-00004","title":"Epirubicin/docetaxel regimen in progressive breast cancer—a phase II study","year":2002,"lang":"en","type":"article","venue":"Anti-Cancer Drugs","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"University Hospital","funders":"","keywords":"Docetaxel; Epirubicin; Medicine; Regimen; Neutropenia; Metastatic breast cancer; Febrile neutropenia; Internal medicine; Breast cancer; Chemotherapy; Adverse effect; Phases of clinical research; Oncology; Surgery; Gastroenterology; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009571904,0.0009233992,0.001822809,0.0003545928,0.0003326001,0.0005642989,0.00062667,0.0006419772,0.002094847],"category_scores_gemma":[0.0004754691,0.0003930707,0.0006934138,0.0003720792,0.0005751046,0.0003795153,0.0001900911,0.002064451,0.0005268056],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000449775,"about_ca_system_score_gemma":0.0009885465,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008854767,"about_ca_topic_score_gemma":0.002442133,"domain_scores_codex":[0.999692,0.0001416379,0.00001507088,0.00004165881,0.00004768091,0.00006209714],"domain_scores_gemma":[0.9996736,0.00005147281,0.00005855619,0.0000301747,0.00002071005,0.0001655285],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3766032,0.2636712,0.01428996,0.001548009,0.001324052,0.001101448,0.0003730463,0.003338559,0.1126663,0.000296921,0.003089989,0.2216974],"study_design_scores_gemma":[0.2012429,0.7679299,0.01890025,0.00004271295,0.0003531372,0.0008146417,0.00005425811,0.0009731099,0.005781218,0.00008464185,0.003801499,0.00002175477],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9958608,0.001825722,0.0002471548,0.0001222793,0.00006285116,0.0008557895,0.0002265126,0.00003335658,0.0007656273],"genre_scores_gemma":[0.9884118,0.004174579,0.001301947,0.0005861361,0.000244788,0.001317785,0.00143328,0.00002097575,0.002508601],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002094847,"threshold_uncertainty_score":0.007007897,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03439308193999131,"score_gpt":0.3809473308364784,"score_spread":0.3465542488964871,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}